{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:41:01Z","timestamp":1774413661055,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jbspin.2016.09.020","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T00:01:13Z","timestamp":1478304073000},"page":"595-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Efficacy and safety of febuxostat in 73 gouty patients with stage 4\/5 chronic kidney disease: A retrospective study of 10 centers"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3766-9600","authenticated-orcid":false,"given":"Pierre-Antoine","family":"Juge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Elise","family":"Truchetet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangeline","family":"Pillebout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Ottaviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Vigneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clotilde","family":"Loustau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divi","family":"Cornec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan","family":"Pascart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaud","family":"Snanoudj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Bailly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Cornec-Le Gall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Schaeverbeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Saraux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Dieud\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9-Marc","family":"Flipo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Richette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Liot\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Chal\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang-Korng","family":"Ea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2016.09.020_bib0105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2369-12-36","article-title":"Chronic kidney disease in gout in a managed care setting","volume":"12","author":"Fuldeore","year":"2011","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0115","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/ndt\/gft029","article-title":"Uric acid and chronic kidney disease: which is chasing which?","volume":"28","author":"Johnson","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0120","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3109\/0886022X.2014.947516","article-title":"Hyperuricemia and chronic kidney disease: an enigma yet to be solved","volume":"36","author":"Dousdampanis","year":"2014","journal-title":"Ren Fail"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0125","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0130","article-title":"updated EULAR evidence-based recommendations for the management of gout","author":"Richette","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0135","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1517\/17425255.2014.915027","article-title":"Pharmacokinetics considerations for gout treatments","volume":"10","author":"Richette","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0140","first-page":"1646","article-title":"Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout","volume":"33","author":"Dalbeth","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/00498250801956350","article-title":"In vitro drug-drug interaction studies with febuxostat, a novel non-purine selective inhibitor of xanthine oxidase: plasma protein binding, identification of metabolic enzymes and cytochrome P450 inhibition","volume":"38","author":"Mukoyoshi","year":"2008","journal-title":"Xenobiotica Fate Foreign Compd Biol Syst"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000434633","article-title":"Population pharmacokinetics and therapeutic efficacy of febuxostat in patients with severe renal impairment","volume":"96","author":"Hira","year":"2015","journal-title":"Pharmacology"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0155","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/0886022X.2013.844622","article-title":"Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease","volume":"36","author":"Sakai","year":"2014","journal-title":"Ren Fail"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0165","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/hr.2014.107","article-title":"Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction","volume":"37","author":"Shibagaki","year":"2014","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/DDDT.S56597","article-title":"Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients","volume":"8","author":"Sofue","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0175","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0180","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","article-title":"Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout","volume":"52","author":"Becker","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0185","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1749-6632.2009.04674.x","article-title":"Colchicine revisited","volume":"1173","author":"Bhat","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0190","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5414\/CN108343","article-title":"Colchicine toxicity in renal patients\u00a0\u2013\u00a0Are we paying attention?","volume":"86","author":"Medani","year":"2016","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0195","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.ajkd.2015.05.017","article-title":"Efficacy of febuxostat for slowing the GFR decline in patients with CKD and asymptomatic hyperuricemia: a 6-month, double-blind, randomized, placebo-controlled trial","volume":"66","author":"Sircar","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jbspin.2016.09.020_bib0200","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/art.39654","article-title":"Impact of febuxostat on renal function in gout subjects with moderate-to-severe renal impairment","volume":"68","author":"Saag","year":"2016","journal-title":"Arthritis Rheumatol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X16301750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X16301750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T19:55:32Z","timestamp":1536263732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X16301750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1297319X16301750"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2016.09.020","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of febuxostat in 73 gouty patients with stage 4\/5 chronic kidney disease: A retrospective study of 10 centers","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2016.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}